Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy.Mads Claus Rasmussen/Ritzau Scanpix / AFP via Getty Images

Europe’s drugs regulator green-lights first oral weight-loss drug – POLITICO

by · POLITICO

The European Medicines Agency backed Novo Nordisk’s weight-loss pill Wegovy on Friday, paving the way for it to be the first oral drug of its kind in Europe.

The tablet will be available with a prescription for adults with obesity or those who are overweight with at least one weight-related other health condition.

So far, only injectable weight-loss drugs have been available in Europe. The injectable version of Wegovy was approved in January 2022 — other weight-loss jabs available in the EU include Eli Lilly’s Mounjaro and Novo’s Saxenda.